{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:05:45Z","timestamp":1784394345678,"version":"3.55.0"},"reference-count":36,"publisher":"Japanese Society of Toxicology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2025]]},"DOI":"10.2131\/jts.50.33","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T22:11:56Z","timestamp":1736201516000},"page":"33-43","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of rewarding effects of nitazene analogs: results from conditioned place preference tests and &lt;i&gt;in vivo&lt;\/i&gt; microdialysis experiments in mice"],"prefix":"10.2131","volume":"50","author":[{"given":"Kyoko","family":"Hataoka","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Hojo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomi","family":"Ikushima","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Inomata","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Environmental Sciences, Tokyo Metropolitan Institute of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","unstructured":"Anonymous. (1959): Addictiveness of two benzimidazole derivatives. Preliminary report. DOC_0000151874. In: US CIA MK-Ultra)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Carroll, M.E. and Meisch, R.A. (1978): Etonitazene as a reinforcer: oral intake of etonitazene by rhesus monkeys. Psychopharmacology (Berl.), <b>59<\/b>, 225-229.","DOI":"10.1007\/BF00426626"},{"key":"3","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3390\/molecules28041601","author":"K. Chaturvedi","year":"2023","unstructured":"Chaturvedi, K., Hewamanna, I., Pandey, P., Khan, W., Wang, Y.H., Chittiboyina, A.G., Doerksen, R.J. and Godfrey, M. (2023): Identification of the Putative Binding Site of a Benzimidazole Opioid (Etazene) and Its Metabolites at \u00b5-Opioid Receptor: A Human Liver Microsomal Assay and Systematic Computational Study. Molecules, <b>28<\/b>, 1601.","journal-title":"Molecules","ISSN":"https:\/\/id.crossref.org\/issn\/1420-3049","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"De Luca, M.A., Tocco, G., Mostallino, R., Laus, A., Caria, F., Musa, A., Pintori, N., Ucha, M., Poza, C., Ambrosio, E., Di Chiara, G. and Castelli, M.P. (2022): Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent \u03bc-opioid receptor agonists. Neuropharmacology, <b>221<\/b>, 109263.","DOI":"10.1016\/j.neuropharm.2022.109263"},{"key":"5","doi-asserted-by":"crossref","unstructured":"De Vrieze, L.M., Walton, S.E., Pottie, E., Papsun, D., Logan, B.K., Krotulski, A.J., Stove, C.P. and Vandeputte, M.M. (2024): In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole \u2018nitazene\u2019 opioids. Arch. Toxicol., <b>98<\/b>, 2999-3018.","DOI":"10.1007\/s00204-024-03774-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Di Trana, A., Pichini, S., Pacifici, R., Giorgetti, R. and Busard\u00f2, F.P. (2022): Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users. Front. Psychiatry, <b>13<\/b>, 858234.","DOI":"10.3389\/fpsyt.2022.858234"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Fadda, P., Scherma, M., Fresu, A., Collu, M. and Fratta, W. (2005): Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA\/2J and C57BL\/6J mice. Synapse, <b>56<\/b>, 29-38.","DOI":"10.1002\/syn.20122"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Funada, M. (2005): [Evaluation of the rewarding effect of drug by conditioned place preference paradigm: its bases and applications]. Nippon Yakurigaku Zasshi, <b>126<\/b>, 10-16.","DOI":"10.1254\/fpj.126.10"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Grigoryev, A., Kavanagh, P., Dowling, G. and Rodin, I. (2023): Tentative Identification of Etazene (Etodesnitazene) Metabolites in Rat Serum and Urine by Gas Chromatography-Mass Spectrometry and Accurate Mass Liquid Chromatography-Mass Spectrometry. J. Anal. Toxicol., <b>46<\/b>, 1032-1037.","DOI":"10.1093\/jat\/bkac001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Gross, F. and Turrian, H. (1957): [Benzimidazole derivatives with strong analgesic effects]. Experientia, <b>13<\/b>, 401-403.","DOI":"10.1007\/BF02161117"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hasegawa, K., Minakata, K., Suzuki, M. and Suzuki, O. (2022): Non-fentanyl-derived synthetic opioids emerging during recent years. Forensic Toxicol., <b>40<\/b>, 234-243.","DOI":"10.1007\/s11419-022-00624-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hataoka, K., Kaizaki-Mitsumoto, A. and Numazawa, S. (2017): Alpha-PVP induces the rewarding effect via activating dopaminergic neuron. J. Toxicol. Sci., <b>42<\/b>, 539-543.","DOI":"10.2131\/jts.42.539"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hataoka, K., Kaizaki-Mitsumoto, A., Takebayashi-Ohsawa, M., Hattori, N., Funada, M. and Numazawa, S. (2019): Hyperreflexia induced by XLR-11 smoke is caused by the pyrolytic degradant. Forensic Toxicol., <b>37<\/b>, 412-423.","DOI":"10.1007\/s11419-019-00476-z"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Huang, X.P., Che, T., Mangano, T.J., Le Rouzic, V., Pan, Y.X., Majumdar, S., Cameron, M.D., Baumann, M.H., Pasternak, G.W. and Roth, B.L. (2017): Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity <i>in vitro<\/i> and <i>in vivo.<\/i> JCI Insight, <b>2<\/b>, e97222.","DOI":"10.1172\/jci.insight.97222"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hunger, A., Kebrle, J., Rossi, A. and Hoffmann, K. (1957): [Synthesis of analgesically active benzimidazole derivatives with basic substitutions]. Experientia, <b>13<\/b>, 400-401.","DOI":"10.1007\/BF02161116"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hunger, A., Kebrle, J., Rossi, A. and Hoffmann, K. (1960a): Benzimidazol-derivate und verwandte Heterocyclen III. Synthese von 1-Aminoalkyl-2-benzyl-nitro-benzimidazolen. Helv. Chim. Acta, <b>43<\/b>, 1032-1046.","DOI":"10.1002\/hlca.19600430412"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Hunger, A., Kebrle, J., Rossi, A. and Hoffmann, K. (1960b): Benzimidazol-Derivate und verwandte Heterocyclen. II. Synthese von 1-Aminoalkyl-2-benzyl-benzimidazolen. Helv. Chim. Acta, <b>43<\/b>, 800-809.","DOI":"10.1002\/hlca.19600430323"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Inomata, A., Ogata, A., Tada, Y., Nagasawa, A., Yuzawa, K., Ando, H., Kubo, Y., Takahashi, H., Kaihoko, F., Tanaka, K., Nakajima, J., Suzuki, A., Uemura, N., Moriyasu, T., Watanabe, D., Ishihara, K., Usami, T., Kamei, S. and Kohno, Y. (2017): [Inhalation Exposure Method for Illegal Drugs]. Yakugaku Zasshi, <b>137<\/b>, 1005-1015.","DOI":"10.1248\/yakushi.17-00019"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Irwin, S. (1968): Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacology (Berl.), <b>13<\/b>, 222-257.","DOI":"10.1007\/BF00401402"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Lee, J.C., Park, H., Eubanks, L.M., Ellis, B., Zhou, B. and Janda, K.D. (2022): A Vaccine against Benzimidazole-Derived New Psychoactive Substances That Are More Potent Than Fentanyl. J. Med. Chem., <b>65<\/b>, 2522-2531.","DOI":"10.1021\/acs.jmedchem.1c01967"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Lowery, J.J., Raymond, T.J., Giuvelis, D., Bidlack, J.M., Polt, R. and Bilsky, E.J. (2011): In vivo characterization of MMP-2200, a mixed \u03b4\/\u03bc opioid agonist, in mice. J. Pharmacol. Exp. Ther., <b>336<\/b>, 767-778.","DOI":"10.1124\/jpet.110.172866"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Morioka, F., Fujii, S., Kamata, H., Shima, N., Tsuboi, K., Katagi, M. and Sato, T. (2023): Postmortem examination and toxicological analysis for acute metonitazene intoxication in Japan: A case report. Leg. Med. (Tokyo), <b>61<\/b>, 102216.","DOI":"10.1016\/j.legalmed.2023.102216"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Nath, C., Gupta, M.B., Patnaik, G.K. and Dhawan, K.N. (1994): Morphine-induced straub tail response: mediated by central mu2-opioid receptor. Eur. J. Pharmacol., <b>263<\/b>, 203-205.","DOI":"10.1016\/0014-2999(94)90543-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Paxinos, G. and Franklin, K.B. (2008): The Mouse Brain in Stereotaxic Coordinates., Academic Press, San Diego.Sala, M., Braida, D., Calcaterra, P., Leone, M.P. and Gori, E. (1992): dose-dependent conditioned place preference produced by etonitazene and morphine. Eur. J. Pharmacol., <b>217<\/b>, 37-41.","DOI":"10.1016\/0014-2999(92)90508-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sala, M., Braida, D., Calcaterra, P., Leone, M.P. and Gori, E. (1992): Dose-dependent conditioned place preference produced by etonitazene and morphine. Eur. J. Pharmacol., <b>217<\/b>, 37-41.","DOI":"10.1016\/0014-2999(92)90508-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Siczek, M., Zawadzki, M., Siczek, M., Ch\u0142opa\u015b-Konowa\u0142ek, A. and Szpot, P. (2021): Etazene (N,N-diethyl-2-{[(4-ethoxyphenyl)methyl]-1H-benzimidazol-1-yl}-ethan-1-amine(dihydrochloride)): a novel benzimidazole opioid NPS identified in seized material: crystal structure and spectroscopic characterization. Forensic Toxicol., <b>39<\/b>, 146-155.","DOI":"10.1007\/s11419-020-00552-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Solimini, R., Pichini, S., Pacifici, R., Busard\u00f2, F.P. and Giorgetti, R. (2018): Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids. Front. Pharmacol., <b>9<\/b>, 654.","DOI":"10.3389\/fphar.2018.00654"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Takeda, A., Doi, T., Asada, A., Suzuki, T., Yuzawa, K., Ando, H., Kubo, Y., Nagasawa, A., Kaihoko, F., Hasegawa, Y., Tanaka, K., Igarashi, K., Maeno, T., Suzuki, A., Shimizu, S., Uemura, N., Nakajima, J., Suzuki, J. and Tagami, T. (2020): Evaluation of carboxamide-type synthetic cannabinoids on the functional activities at cannabinoid receptors and biological effects via inhalation exposure test. Forensic Toxicol., <b>38<\/b>, 455-464.","DOI":"10.1007\/s11419-020-00534-x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Taoussi, O., Berardinelli, D., Zaami, S., Tavoletta, F., Basile, G., Kronstrand, R., Auw\u00e4rter, V., Busard\u00f2, F.P. and Carlier, J. (2024): Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene. Arch. Toxicol., <b>98<\/b>, 2101-2116.","DOI":"10.1007\/s00204-024-03735-0"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Tirri, M., Corli, G., Arf\u00e8, R., Marchetti, B., Bilel, S., Bernardi, T., Boccuto, F., Odoardi, S., Mestria, S., Strano-Rossi, S. and Marti, M. (2023): Behavioral and Pharmacokinetics Studies of <i>N<\/i>-Methyl-2-Aminoindane (NM2AI) in Mice: An Aminoindane Briefly Used in the Illicit Drug Market. Int. J. Mol. Sci., <b>24<\/b>, 1882.","DOI":"10.3390\/ijms24031882"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Ujv\u00e1ry, I., Christie, R., Evans-Brown, M., Gallegos, A., Jorge, R., de Morais, J. and Sedefov, R. (2021): DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles. ACS Chem. Neurosci., <b>12<\/b>, 1072-1092.","DOI":"10.1021\/acschemneuro.1c00037"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Vandeputte, M.M., Krotulski, A.J., Papsun, D.M., Logan, B.K. and Stove, C.P. (2021a): The Rise and Fall of Isotonitazene and Brorphine: Two Recent Stars in the Synthetic Opioid Firmament. J. Anal. Toxicol., <b>46<\/b>, 115-121.","DOI":"10.1093\/jat\/bkab082"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Vandeputte, M.M., Van Uytfanghe, K., Layle, N.K., St Germaine, D.M., Iula, D.M. and Stove, C.P. (2021b): Synthesis, Chemical Characterization, and \u03bc-Opioid Receptor Activity Assessment of the Emerging Group of \u201cNitazene\u201d 2-Benzylbenzimidazole Synthetic Opioids. ACS Chem. Neurosci., <b>12<\/b>, 1241-1251.","DOI":"10.1021\/acschemneuro.1c00064"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Varshneya, N.B., Walentiny, D.M., Moisa, L.T., Walker, T.D., Akinfiresoye, L.R. and Beardsley, P.M. (2021): Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors. Pharmacol. Biochem. Behav., <b>208<\/b>, 173242.","DOI":"10.1016\/j.pbb.2021.173242"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Walton, S.E., Krotulski, A.J., Glatfelter, G.C., Walther, D., Logan, B.K. and Baumann, M.H. (2023): Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats. Psychopharmacology (Berl.), <b>240<\/b>, 185-198.","DOI":"10.1007\/s00213-022-06292-5"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Walton, S.E., Krotulski, A.J. and Logan, B.K. (2022): A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS). J. Anal. Toxicol., <b>46<\/b>, 221-231.","DOI":"10.1093\/jat\/bkab117"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/1\/50_33\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T04:18:16Z","timestamp":1736569096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/1\/50_33\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.50.33","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}